Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q4 2025 Earnings

13NovConfirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-1

-0.78

-0.57

-0.35

Details

Expected EPS

-0.386923

Actual EPS

-0.48

Surprise EPS

-0.09

Surprise Percent

+24.06%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.48 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.